Clinical Trials Directory

Trials / Completed

CompletedNCT02068781

Aldosterone, Microvascular Function and Salt-sensitivity

Aldosterone-induced Microvascular Dysfunction as a Cause of Salt-sensitivity in Obesity?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Currently, the incidence of obesity and obesity-related disorders is reaching epidemic proportions, which entails an increasing burden for health care systems. The association of obesity with other risk factors for type 2 diabetes mellitus and cardiovascular disease, such as insulin resistance and hypertension, is often referred to as the metabolic syndrome. During recent years, salt-sensitivity of blood pressure has emerged as an additional cardiovascular risk factor that is related to obesity and other key components of the metabolic syndrome. The underlying pathophysiological mechanisms of these interrelationships are complex and incompletely elucidated. Microvascular dysfunction has been proposed as a link between insulin resistance and hypertension in obese individuals. In addition, impairment of microvascular function was found to be associated with salt-sensitivity of blood pressure. Increased aldosterone levels, as observed in obese individuals, might be a cause of microvascular dysfunction-induced salt-sensitivity and insulin resistance. Aldosterone not only gives rise to sodium-retention in the distal tubule of the kidney, but was also found to impair endothelial function and thus lower NO-availability, which is characteristic of microvascular dysfunction. In addition, elevated aldosterone levels are associated with both hypertension and insulin resistance, which is illustrated in patients with primary aldosteronism, but also in the general population. The investigators hypothesize that increased aldosterone levels in obese individuals lead to impairment of microvascular function through reduction of NO-availability. This microvascular dysfunction is suggested to play a central role in the pathogenesis of salt-sensitive hypertension and insulin resistance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow-sodium diet50 mmol NaCl per 24h
DIETARY_SUPPLEMENTHigh-sodium diet250 mmol NaCl per 24h

Timeline

Start date
2014-07-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2014-02-21
Last updated
2017-05-19

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02068781. Inclusion in this directory is not an endorsement.